Close

Analyst Ratings for Lexicon Pharmaceuticals (LXRX)

LXRX Rating Summary

LXRX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on LXRX
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $8.00 (+296%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 29%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/12/2022 Piper Sandler Yasmeen Rahimi New Coverage Overweight
(N/A)
10.00
(N/A)
2.78
(2.02)
-27.34% Details
1/29/2021 Wedbush Liana Moussatos Downgrade Neutral
(Outperform)
8.00
(2.00)
8.06
(2.02)
-74.94% Details